成都企业，掀起IPO热潮

Core Viewpoint - Chengdu enterprises are actively engaging in the capital market, with several companies from the semiconductor and biopharmaceutical sectors initiating IPO processes, indicating the city's growth vitality and potential in these industries [1][2]. Semiconductor Sector - The semiconductor industry in Chengdu is experiencing significant growth, with companies like Chengdu Super Pure Materials Co., Ltd. and Chengdu Starway Microelectronics Co., Ltd. leading the charge in IPO applications [3][4]. - Chengdu Super Pure Materials aims to raise 1.12468 billion yuan through its IPO, focusing on precision components for semiconductor manufacturing and optical fields, holding a 5.7% market share in mainland China [4][6]. - Chengdu Starway Microelectronics, founded in 2019, has initiated its A-share IPO process and has secured over 230 invention patents, emphasizing its strong R&D capabilities [6][8]. Biopharmaceutical Sector - Chengdu has a well-established biopharmaceutical industry, transitioning from generic drugs to innovative drug development, with companies like Zeling Biopharmaceutical Technology Co., Ltd. and Olin Bio leading recent IPO efforts [9][10]. - Zeling Biopharmaceutical completed a 600 million yuan Series C financing round and has submitted its IPO application to the Hong Kong Stock Exchange shortly after [10][13]. - Olin Bio, a veteran in the vaccine sector, has also applied for an H-share listing on the Hong Kong Stock Exchange, highlighting the ongoing growth in Chengdu's biopharmaceutical landscape [13]. Diverse Industry Growth - Chengdu is witnessing a surge in various sectors, with many companies characterized as "specialized, refined, and innovative" preparing for IPOs [14][18]. - Companies like Sentai Precision Tools Co., Ltd. and Hongming Electronics Co., Ltd. are making strides in their respective fields, with Sentai completing IPO counseling for the Beijing Stock Exchange and Hongming successfully passing the IPO review for the Shenzhen Stock Exchange [15][17]. - The "Rongyi Shang" system in Chengdu is facilitating a supportive environment for IPOs, with over 700 potential listing companies and 2,900 high-growth enterprises being nurtured [18].